Cronstein B N, Daguma L, Nichols D, Hutchison A J, Williams M
Department of Medicine, New York University Medical Center, New York 10016.
J Clin Invest. 1990 Apr;85(4):1150-7. doi: 10.1172/JCI114547.
Occupancy of specific receptors on neutrophils by adenosine or its analogues diminishes the stimulated release of toxic oxygen metabolites from neutrophils, while paradoxically promoting chemotaxis. We now report evidence that two distinct adenosine receptors are found on neutrophils (presumably the A1 and A2 receptors of other cell types). These adenosine receptors modulate chemotaxis and O2- generation, respectively. N6-Cyclopentyladenosine (CPA), a selective A1 agonist, promoted neutrophil chemotaxis to the chemoattractant FMLP as well as or better than 5'N-ethylcarboxamidoadenosine (NECA). In contrast, CPA did not inhibit O2- generation stimulated by FMLP. Pertussis toxin completely abolished promotion of chemotaxis by CPA but enhanced inhibition by NECA of O2- generation. Disruption of microtubules by colchicine or vinblastine also abrogated the enhancement by NECA of chemotaxis whereas these agents did not markedly interfere with inhibition by NECA of O2- generation. FMLP receptors, once they have bound ligand, shift to a high affinity state and become associated with the cytoskeleton. NECA significantly increased association of [3H]FMLP with cytoskeletal preparations as it inhibited O2-. Disruption of microtubules did not prevent NECA from increasing association of [3H]FMLP with cytoskeletal preparations. Additionally, CPA (A1 agonist) did not increase binding of [3H]FMLP to the cytoskeleton as well as NECA (A2 agonist). These studies indicate that occupancy of one class of adenosine receptors (A1) promotes chemotaxis by a mechanism requiring intact microtubules and G proteins whereas engagement of a second class of receptors (A2) inhibits O2- generation. Signalling via A2 receptors is independent of microtubules, insensitive to pertussis toxin and is associated with binding of [3H]FMLP to cytoskeletal preparations.
腺苷或其类似物占据中性粒细胞上的特定受体,可减少中性粒细胞受刺激后有毒氧代谢产物的释放,而自相矛盾的是,这却能促进趋化作用。我们现在报告有证据表明,在中性粒细胞上发现了两种不同的腺苷受体(推测为其他细胞类型的A1和A2受体)。这些腺苷受体分别调节趋化作用和O2-生成。N6-环戊基腺苷(CPA),一种选择性A1激动剂,促进中性粒细胞向趋化因子FMLP的趋化作用,效果与5'-N-乙基羧酰胺腺苷(NECA)相同或更好。相比之下,CPA并不抑制FMLP刺激的O2-生成。百日咳毒素完全消除了CPA对趋化作用的促进,但增强了NECA对O2-生成的抑制。秋水仙碱或长春碱破坏微管也消除了NECA对趋化作用的增强,而这些药物并未明显干扰NECA对O2-生成的抑制。FMLP受体一旦结合配体,就会转变为高亲和力状态并与细胞骨架结合。NECA在抑制O2-时显著增加了[3H]FMLP与细胞骨架制剂的结合。微管的破坏并未阻止NECA增加[3H]FMLP与细胞骨架制剂的结合。此外,CPA(A1激动剂)与NECA(A2激动剂)相比,并没有增加[3H]FMLP与细胞骨架的结合。这些研究表明,一类腺苷受体(A1)的占据通过一种需要完整微管和G蛋白的机制促进趋化作用,而另一类受体(A2)的结合则抑制O2-生成。通过A2受体的信号传导独立于微管,对百日咳毒素不敏感,并且与[3H]FMLP与细胞骨架制剂的结合有关。